Delivery Order SPE2DB22D1017-SPE2DB25FYSHK
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,501.50 for Trulicity 3 mg/0.5 mL pens on May 30, 2025, with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order for pharmaceutical supply to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $3,073.44 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $11,940.80 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Trulicity 3 mg/0.5 mL pens with an ultimate completion date of September 24, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,097.04 to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 ml pens on April 24, 2025, with completion scheduled for April 25, 2025. This competitive award utilizes firm fixed pricing and does not include a set-aside designation. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen operates as a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $45,584.97 for Trulicity 3 mg/0.5 ml pens on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed price contract, which was not set-aside, represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $1,201.20 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens (0.5 ml units). This competitive award, issued on September 25, 2025, with an ultimate completion date of September 26, 2025, reflects a firm fixed price delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a $1,801.80 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Trulicity 3 mg/0.5 ml pens (0.5 ml doses). This firm fixed-price delivery order, with an ultimate completion date of June 3, 2025, represents a non-set-aside competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $1,958.49 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pens (0.5 ml) on September 8, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price, non-set-aside delivery order will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier to the federal government's military...
- The Defense Logistics Agency awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on September 23, 2025, with completion expected by September 24, 2025. This is a firm fixed-price contract with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,514.37 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 12, 2025, with an ultimate completion date of August 13, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYSHKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 ml pens on September 29, 2025, with completion expected by September 30, 2025. This firm fixed price delivery order represents a single transaction under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The award carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from the contractor's Conshohocken, Pennsylvania facility, which serves as the company's corporate headquarters and a critical distribution hub for federal pharmaceutical procurement. This delivery order is issued under AmerisourceBergen's prime indefinite delivery contract (SPE2DX) valued at $999,999,999.00 and extending through December 2026, which functions as a comprehensive global pharmaceutical support vehicle for military healthcare programs. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen maintains an extensive portfolio of federal medical product contracts with DLA, supplying diabetes medications, specialty pharmaceuticals, vaccines, medical devices, and related healthcare commodities to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The delivery of Trulicity, a diabetes treatment medication, exemplifies the company's role in providing critical brand-name pharmaceuticals to support military and federal healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/29/25 |